A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2694-2698

  Legro, Richard S ^a   Finegood, Diane ^b   Dunaif, Andrea ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b SIMON FRASER UNIVERSITY   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SCREENING TEST;

ADOLESCENT; ADULT; BLOOD GLUCOSE; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; KINETICS; POLYCYSTIC OVARY SYNDROME;

FALLOPIA;

EID: 0031787388     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2694     Document Type: Article

References (31)

1. Dunaif A, Givens JR, Haseltine FP, Merriam GR. 1992 Current issues in endocrinology and metabolism: polycystic ovary syndrome. Boston: Blackwell.
2. Burghen GA, Givens JR, Kitabchi AE. 1980 Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 50:113-116.
3. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:356-359.
4. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165-1174.
5. Laakso M. 1993 How good a marker is insulin level for insulin resistance? Am J Epidemiol. 137:959-965.
6. American Diabetic Association. 1998 Consensus Development Conference on Insulin Resistance: 5-6 November 1997. Diabetes Care. 21:310-314.
7. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. 1996 The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:3299-3306.
8. Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Polonsky KS. 1997 Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:2108-2116.
9. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. 1994 Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism. 43:647-654.
10. Nestler JE, Jakubowicz DJ. 1996 Decreases in ovarian cytochrome P450C17-α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 335:617-623.
11. Modan M, Harris MI, Halkin H. 1989 Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples. Diabetes. 38:1630-1635.
12. Bergman RN, Phillips LS, Cobelli C. 1981 Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 68:1456-1467.
13. Bergman RN. 1989 Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 38:1512-1527.
14. Dunaif A, Finegood DT. 1996 Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:942-447.
15. Tai MM. 1994 A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care. 17:152-154.
16. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 65:499-507.
17. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 41:1257-1266.
18. Dunaif A. 1992 Insulin resistance and ovarian hyperandrogenism. Endocrinologist. 2:248-260.
19. Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ. 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 36:105-111.
20. Nestler JE, Barlascini CO, Matt DW, et al. 1989 Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 68:1027-1032.
21. Prelevic GM, Wurzburger MI, Balint-Peric L, Nesic JS. 1990 Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet. 336:900-903.
22. Velazquez E, Acosta A, Mendoza SG. 1997 Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol. 90:392-395.
23. Nagasaka S, Iwamoto Y, Ishikawa S, Kuzuya T, Saito T. 1997 Efficacy of troglitazone measured by insulin resistance index. Lancet. 350:184.
24. Reaven GM. 1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
25. Ferrannini E, Natali A, Bell P, et al. 1997 Insulin resistance and hypersecretion in obesity. J Clin Invest. 100:1166-1172.
26. Parra A, Ramirez A, Espinosa de los Monteros A. 1994 Fasting glucose/ insulin ratio. An index to differentiate normo from hyperinsulinemic women with polycystic ovary syndrome. Rev Invest Clin. 46:363-368.
27. Saad MF, Anderson RL, Laws A, et al. 1994 A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes. 43:1114-1121.
28. Dunaif A. 1997 Insulin resistance and polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocr Rev. 18:774-800.
29. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. 1996 Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes. 45:947-953.
30. Dunaif A, Sorbara L, Delson R, Green G. 1993 Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes. 42:1462-1468.
31. Norman RJ, Mahabeer S, Masters S. 1995 Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil Steril. 63:58-62.